Why the study?
Does PCR-based gene amplification improve the detection of viral persistence in the hearts of mice with experimental coxsackievirus B3 myocarditis compared to viral isolation?
Does PCR-based gene amplification improve the detection of viral persistence in the hearts of mice with experimental coxsackievirus B3 myocarditis compared to viral isolation?
PCR-based gene amplification allows for the detection of persistent viral RNA in experimental myocarditis even after infectious virus is no longer detectable by standard isolation methods.
Answers are grounded in this paper and cite their sources.
PCR extends detection of viral persistence in murine myocarditis models; leaves open relevance to human diagnosis or therapy.
On the basis of the detection of the enteroviral RNA in the hearts of patients with healed myocarditis and dilated cardiomyopathy, we investigated cardiac viral persistence in experimental myocarditis. Weanling C3H/He mice were given myocarditis by inoculation with coxsackievirus B3 (Nancy strain), and their hearts were examined by genomic studies and viral isolation up to the 180th day after inoculation. The virus was isolated from the heart until the 9th day. By slot-blot hybridization, viral RNA was also only detected until the 9th day in the heart. Specific DNA amplification using the polymerase chain reaction (PCR) was performed after a reverse transcriptase reaction, then followed by Southern blot hybridization with a 32P-labelled oligomer probe. This technique achieved the type-specific detection of coxsackievirus B3 even at a level of less than one of the 50% tissue culture infective dose (TCID50). With this technique, viral RNA was detected up to the 28th day after inoculation. Thus, the viral RNA persisted in the hearts of these mice even when infectious virus could no longer be detected.
No takes yet. Share an insight, caveat, or question.
Koide et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: